Liquidia Execs Load Up on Shares Amid 24% Weekly Surge, Signals Management Confidence in Biopharma Pipeline
Liquidia’s insider buying shows management confidence in its biopharma pipeline—key takeaways for investors and insight into future upside.
5 minutes to read